Halcion (Triazolam)

Halcion (triazolam) is a benzodiazepine that is primarily indicated for the short‑term treatment of insomnia, especially when difficulty falling asleep is a major concern and other measures have not provided adequate relief.

• Short‑term relief of transient insomnia
• Use in adults when non‑pharmacologic measures are insufficient
• Adjunct to behavioral sleep therapy
• Limited use in patients with severe sleep onset latency
• May be prescribed for brief periods before travel or shift changes

Side effects of Halcion vary in frequency and severity; they are typically categorized as common, mild reactions and less frequent, serious events that may require medical attention.

Common

• Drowsiness or fatigue, which may affect daytime alertness
• Dizziness or light‑headed feeling, especially after standing quickly
• Short‑term memory impairment, such as difficulty recalling recent events
• Headache, mild nausea, or gastrointestinal discomfort
• Impaired coordination, increasing risk of falls or accidents

Serious

• Severe allergic reaction, including rash, swelling of the face or throat, or difficulty breathing
• Paradoxical reactions such as agitation, aggression, anxiety, or visual hallucinations

When prescribing or using Halcion, clinicians and patients should observe several precautions to minimize risks and ensure safe use.

• Limit use to short durations (typically ≤2 weeks) to avoid dependence
• Avoid use in patients with a history of substance abuse or severe depression
• Do not operate machinery or drive until you know how the medication affects you
• Caution in elderly patients due to increased sensitivity and fall risk
• Pregnancy and breastfeeding status should be evaluated; use only if benefits outweigh risks
• Concurrent use with other central nervous system depressants can enhance sedation
• Gradual tapering is recommended when discontinuing after prolonged therapy

Halcion can interact with other medicines, altering its sedative effect or increasing the risk of adverse reactions; awareness of these interactions helps guide safe therapy.

Avoid

• Other benzodiazepines or barbiturates, which can cause excessive sedation or respiratory depression
• Opioid analgesics, due to additive central nervous system depression
• Alcohol, because it intensifies sedative effects and impairs coordination

Use with caution

• Antidepressants such as SSRIs or SNRIs, which may affect metabolism of triazolam
• Antifungal agents (e.g., ketoconazole) or macrolide antibiotics, which can inhibit CYP3A4 and raise triazolam levels
• Antihistamines or antipsychotics, which may increase drowsiness